Entries by Rebecca Mercer

Responses to Stakeholder Feedback re: CanREValue Interim Policy Report now available!

As part of a broader engagement strategy, the CanREValue Collaboration has launched a stakeholder consultation process. Earlier in 2020, the CanREValue Collaboration undertook public stakeholder consultation regarding the Interim Policy Report developed by the CanREValue Working Groups. From this consultation, we received 21 constructive submissions from a diverse set of (more…)

Recruiting: The Ottawa Hospital – Jr. Health Economist

Posting Date: October 19, 2020 Closing Date: October 28, 2020 For full details and to apply on-line, please visit http://www.ohri.ca/Careers/Details.aspx?CareerID=1483 Job Description: Duties and Responsibilities: • Design and undertake health economic analyses of health care interventions using various methods such as state-transition, microsimulation, and discrete event simulation models as well as regression analyses, (more…)

Position Opportunity: Research Associate in Child Health Evaluative Sciences

To find out more or to apply online for this position please visit: https://career.sickkids.ca:8001/psc/CRPRD/CAREER/HRMS/c/HRS_HRAM.HRS_APP_SCHJOB.GBL?Page=HRS_APP_JBPST&Action=U&FOCUS=Applicant&SiteId=1&JobOpeningId=12982&PostingSeq=1& Position Description:  The Child Health and Evaluative Sciences (CHES) program at the Hospital for Sick Children is seeking a Research Associate. CHES is a team of multidisciplinary faculty and staff with a core mission to conduct (more…)

Ontario Drug Policy Research Network – Student Training Program

Find out more online at https://odprn.ca/about-the-odprn/student-training-program/ The ODPRN Student Training Program aims to engage with students to develop capacity in drug policy research in Ontario. Trainees involved in this one-year collaborative program will work towards obtaining a drug policy training research certificate through the ODPRN. Through this program, trainees will (more…)

Health Economics Opportunities with CPAC

The Canadian Partnership Against Cancer has openings for a Health Economist and a Health Economics Fellow. Health Economist Closing Date: September 21, 2020 This position is part of the Partnership’s Cancer Systems, Performance and Innovation Division. This division drives improvements in Canada’s cancer system through data, research, economic modelling and innovations (more…)

Participants Needed: Have your say in the evaluation of CAR T-Cell Therapy

Stakeholder engagement in an economic evaluation of CAR-T cell therapy: improving economic evaluation with stakeholder-specific input  Principal Investigator: Dr. Justin Presseau Co-Principal Investigators: Dr. Kednapa Thavorn Co-Investigators: Dr. Natasha Kekre, Dr. Harry Atkins, Dr. Doug Coyle, Dr. Dean Fergusson, Mr. Terry Hawrysh, Dr. Ian Graham, Dr. Brian Hutton, Dr. Jeremy (more…)

Canadian Knowledge Mobilization Forum 2020 – now Virtual!

The Canadian Knowledge Mobilization Forum for 2020 is being re-imagined online! We hope that you will join us (from wherever you are)! About this Event The Canadian Knowledge Mobilization Forum (CKF) is a professional development, learning, and networking event for those working in knowledge mobilization/translation/exchange. Drawing from expertise across different sectors, we are (more…)

Invitation to Participate: Online survey to share your thoughts on COVID-19 stigma, fear, and misinformation

While not cancer specific, we thought you may be interested in the below opportunity! *** We would like to invite you to consider participating in an online survey to provide your thoughts and perceptions on how stigma, fear and misinformation spreads during COVID-19. The survey is anonymous and completely confidential and should (more…)

New Partnership: ARCC joins CCTG trial aimed at protecting cancer patients from COVID-19

The Canadian Cancer Trials Group (CCTG) has launched a new trial focusing on strengthening the immune system in cancer patients, CCTG IC.8:  Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure (COV-IMMUNO). Funding and in-kind support, valued (more…)

CCTG IC.8 COV-IMMUNO- A randomized phase III trial of immunization with IMM-101 versus observation for the prevention of serious respiratory and COVID-19 related infections in cancer patients at increased risk of exposure

Lead Investigator(s): Rebecca Auer (The Ottawa Hospital), Chris O’Callaghan (Queen’s University) Co-Investigators: John Bartlett, Laszlo Radvanyi, Dongsheng Tu, Janet Dancey, Scott Halperin, Kelvin Chan, Nicole Mittmann, Martin Smoragiewicz, Grainne O’Kane, George Zogopoulos, Jonathon Loree, Rosalyn Juergens, Eric Winquist, Judy Needham, David Roberge ARCC Program Area(s): Health Technology Assessment Main Funder/Other (more…)